◼ Archived
Health
Pittsburgh cancer doctors explain why less treatment can sometimes mean better outcomes
Pittsburgh cancer doctors and precision oncology editors explain why less treatment can sometimes mean better outcomes.
3 trends tracked about this subject — the full history, oldest to newest below.
Pittsburgh cancer doctors and precision oncology editors explain why less treatment can sometimes mean better outcomes.
A breakthrough pancreatic cancer drug wins FDA approval and hits the clinic, raising questions over patient access.
Tempus AI is acquiring cancer-monitoring firm Personalis in a deal valued at approximately $1.5 billion, though market reaction has been negative.